IDEX Corporation (IEX) Stock: Price, Forecast & Analyst Target
IDEX Corporation (IEX) — MoonshotScore 81/100 (Exceptional band), calculated Nov 18, 2026. Price $227.06 (-2.61%), as of the Nov 19, 2026 trading session; market cap $16.7B. Expected results Feb 3, 2027.
Educational signal · not a buy or sell recommendation · How to read this
IDEX Corporation · IEX · NYSE · Industrials · Industrial - Machinery
Research dated 2026-09-12: IDEX sells specialized pumps, meters, fluidic devices, optical components, rescue equipment and dispensing systems across industrial, scientific and emergency-service markets. The case now depends on whether broadening demand can sustain the latest profit and cash-flow improvement while the company carries materially more debt than cash.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · IDEX (IEX)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, a strong balance sheet and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Rich; Growth Durability: Growing; Momentum: Surging.
Enterprise value relative to sales is the main valuation drag relative to sector peers.
- EPS beat 0 of the last 4 reports
- expected results Feb 3, 2027
- Altman Z 5.64 · Piotroski F 8
Holding back: a rich price
Helping: business quality, balance-sheet strength, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 78 | Strong | |
| 79 | Strong | |
| 78 | Strong | |
| 78 | Strong | |
| 81 | Exceptional | |
| 81 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $227.06 | |
| Change on the day | -2.61% | |
| 52-week range | $160.60–$243.80 | |
| Market capitalisation | $16.7B | — |
| Price / earnings (trailing) | 32.21 | |
| Shares traded on the day | 537.1K | |
| Beta (volatility vs the S&P 500) | 0.95 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for IDEX (IEX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is IDEX (IEX), and what does it report?
Short answer · as of
IDEX is not simply a machinery producer. Its products control, move, measure, seal, mix or dispense fluids and materials, support precision optical and medical applications, and equip firefighters and rescue teams; customer activity in those applications is the underlying unit of demand.
Research dated 2026-09-12.
Reporting divides that portfolio among Fluid and Metering Technologies, Health and Science Technologies, and Fire and Safety Diversified Products. Health and Science Technologies is the largest revenue contributor, Fluid and Metering Technologies follows, and Fire and Safety Diversified Products remains meaningful but smaller.
What do the latest results show for IDEX (IEX)?
Research dated 2026-09-12.
Revenue, gross profit, operating profit, net income and diluted earnings all rose from the preceding period. Operating cash flow also rebounded sharply, while capital spending remained modest beside the cash produced.
Management said performance meaningfully exceeded its guidance and raised its organic-growth outlook. Reported revenue and adjusted earnings also cleared market estimates in the latest release, extending a generally favorable run against expectations; the guidance change is management's expectation, not evidence that the expansion has already been delivered.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $879M | $128M | $1.70 (diluted) |
| Q4 FY2025 | $899M | $128M | $1.72 (diluted) |
| Q1 FY2026 | $887M | $120M | $1.61 (diluted) |
| Q2 FY2026 | $921M | $143M | $1.93 (diluted) |
What are the financial strengths and risks for IDEX (IEX)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12.
IDEX combines healthy operating margins, recurring positive cash generation and limited capital spending with strong short-term liquidity measures. Cash and short-term investments have risen from their recent low and remain close to the level at the beginning of the displayed history, while quality and distress screens are favorable.
Debt nevertheless stands well above cash and investments, leaving the company in a net-debt position. A synchronized slowdown across life-science systems, industrial fluid handling and emergency or dispensing equipment would pressure several revenue streams at once and make cash conversion more important to balance-sheet flexibility.
What should you watch next at IDEX (IEX)?
Short answer · as of
The next earnings report is expected on Feb 3, 2027.
Research dated 2026-09-12.
Organic growth is the immediate operating test: reported results need to support management's raised outlook without sacrificing the margin level it outlined. Revenue and adjusted earnings should also be compared with market expectations, but the more useful confirmation would be simultaneous growth in gross profit, operating profit and operating cash flow.
Cash conversion deserves particular attention after the latest rebound, especially while debt remains above cash. Investors should also watch how the newly disclosed material agreement affects financing obligations or capital allocation once its economic consequences appear in subsequent reporting.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does IDEX compare with its peers?
Short answer
IDEX's score ranks 5th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
IDEX differs from a focused pump manufacturer because fluid handling is only part of the portfolio. Precision photonics, biocompatible medical components, fire and rescue tools, industrial clamping systems and colorant-dispensing equipment expose it to distinct customer workflows under the same corporate structure.
The revenue mix is correspondingly distributed rather than dependent on a single product family, with Health and Science Technologies contributing the most. That breadth can soften a localized market decline, but it also requires investors to judge several end-market cycles rather than treating IDEX as a uniform industrial-volume business.
| Company | Price | Market value | Score |
|---|---|---|---|
| $356.60 Nov 19, 2026 | $11.9B | 93 5-pillar Nov 18, 2026 | |
| $71.61 Nov 18, 2026 | $11.5B | 90 5-pillar Nov 18, 2026 | |
| $267.69 Nov 18, 2026 | $14.5B | 85 5-pillar Nov 18, 2026 | |
| $316.81 Nov 19, 2026 | $17.7B | 83 5-pillar Nov 18, 2026 | |
| IDEX (IEX) — this page | $227.06 | $16.7B | 81 |
| $84.77 Nov 18, 2026 | $9.82B | 78 5-pillar Nov 18, 2026 | |
| $68.37 Nov 18, 2026 | $10.9B | 72 5-pillar Nov 18, 2026 | |
| $202.69 Nov 18, 2026 | $27.0B | 72 5-pillar Nov 18, 2026 | |
| $209.12 Nov 19, 2026 | $12.1B | 69 5-pillar Nov 18, 2026 | |
| $95.20 Nov 18, 2026 | $21.8B | 67 5-pillar Nov 18, 2026 | |
| $208.92 Nov 18, 2026 | $18.6B | 63 5-pillar Nov 18, 2026 | |
| $205.45 Nov 18, 2026 | $12.1B | 63 5-pillar Nov 18, 2026 | |
| $81.46 Nov 18, 2026 | $10.3B | 60 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $245.00 – $280.00
- Consensus target
- $266.13
- Median target
- $270.00
Consensus record · Captured .
Measured against a quoted price of $227.06 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 16, 2026
- Transactions
- 7
- Identified insiders
- 4
- Purchases
- 0
- Sales
- 1
- Other transactions
- 6
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held IEX in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported IEX in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about IDEX (IEX)?
IEX Industrials Stock FAQ
Research dated 2026-09-12; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
What does IDEX Fluid and Metering Technologies sell?
The segment makes pumps, flow meters, injectors and monitoring equipment used to move and measure fluids in food, chemical, water, agricultural, energy and general industrial applications. Demand therefore reflects customer activity across several process markets rather than purchases of a single machinery category.
Why is Health and Science Technologies important to IDEX?
It is IDEX's largest revenue segment and spans precision fluidics, pumps, drying and compaction technologies, sealing products, medical devices, optics and photonics. Its exposure reaches life sciences, pharmaceuticals, food, wastewater, marine and defense applications.
How do fire pumps and colorant dispensers fit inside IDEX?
Both sit within Fire and Safety Diversified Products alongside rescue tools, lifting equipment and engineered banding and clamping products. The segment joins emergency-service equipment with specialized systems that meter and mix paints and colorants for commercial customers.
Can IDEX cash generation absorb its debt burden?
Operating cash flow has remained positive and strengthened in the latest period, with capital spending consuming a relatively small share. Debt still materially exceeds cash and investments, so sustained cash conversion matters more than the headline cash balance alone.
What is the IEX stock price today?
The last price recorded for IDEX Corporation (IEX), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the IEX price target?
The analyst consensus price target for IDEX Corporation (IEX), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 25 figures on this page — 1 from SEC filings and earnings calls, 19 from Financial Modeling Prep (FMP), 3 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com